Offline
Panacea Biotech
BSE: 531349 | NSE: PANACEABIO | ISIN: INE922B01023 | Pharmaceuticals
 |
| Profit & Loss account | ------------------- in Rs. Cr. ------------------- |
| Mar '04 | Mar '05 | Mar '06 | Mar '07 | Mar '08 | ||||||
|
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| Income | ||||||||||
| Sales Turnover | 273.55 | 339.15 | 548.69 | 842.95 | 837.00 | |||||
| Excise Duty | 10.52 | 10.22 | 11.62 | 8.45 | 3.78 | |||||
| Net Sales | 263.03 | 328.93 | 537.07 | 834.50 | 833.22 | |||||
| Other Income | 5.25 | -0.98 | 5.98 | 26.46 | 18.02 | |||||
| Stock Adjustments | 24.12 | 35.41 | -0.30 | -11.76 | -2.18 | |||||
| Total Income | 292.40 | 363.36 | 542.75 | 849.20 | 849.06 | |||||
| Expenditure | ||||||||||
| Raw Materials | 153.20 | 193.39 | 268.26 | 378.29 | 368.27 | |||||
| Power & Fuel Cost | 3.01 | 4.16 | 6.13 | 9.41 | 9.69 | |||||
| Employee Cost | 32.17 | 35.18 | 42.97 | 78.80 | 92.49 | |||||
| Other Manufacturing Expenses | 3.00 | 4.62 | 4.19 | 4.54 | 4.45 | |||||
| Selling and Admin Expenses | 46.82 | 49.32 | 84.00 | 115.30 | 138.57 | |||||
| Miscellaneous Expenses | 8.19 | 9.46 | 9.42 | 12.17 | 12.40 | |||||
| Preoperative Exp Capitalised | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Total Expenses | 246.39 | 296.13 | 414.97 | 598.51 | 625.87 | |||||
| Mar '04 | Mar '05 | Mar '06 | Mar '07 | Mar '08 | ||||||
|
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| Operating Profit | 40.76 | 68.21 | 121.80 | 224.23 | 205.17 | |||||
| PBDIT | 46.01 | 67.23 | 127.78 | 250.69 | 223.19 | |||||
| Interest | 13.93 | 11.20 | 13.33 | 17.04 | 15.01 | |||||
| PBDT | 32.08 | 56.03 | 114.45 | 233.65 | 208.18 | |||||
| Depreciation | 9.97 | 13.60 | 13.92 | 24.52 | 29.87 | |||||
| Other Written Off | 0.48 | 0.48 | 0.48 | 0.26 | 0.17 | |||||
| Profit Before Tax | 21.63 | 41.95 | 100.05 | 208.87 | 178.14 | |||||
| Extra-ordinary items | 1.59 | 0.88 | 0.14 | 0.23 | 12.32 | |||||
| PBT (Post Extra-ord Items) | 23.22 | 42.83 | 100.19 | 209.10 | 190.46 | |||||
| Tax | 6.77 | 12.76 | 39.24 | 62.29 | 57.30 | |||||
| Reported Net Profit | 16.45 | 30.07 | 60.94 | 146.81 | 133.17 | |||||
| Total Value Addition | 93.19 | 102.75 | 146.72 | 220.22 | 257.61 | |||||
| Preference Dividend | 0.82 | 4.39 | 4.07 | 2.04 | 0.00 | |||||
| Equity Dividend | 5.71 | 8.56 | 5.71 | 6.57 | 6.67 | |||||
| Corporate Dividend Tax | 0.84 | 1.77 | 1.37 | 1.40 | 1.13 | |||||
| Per share data (annualised) | ||||||||||
| Shares in issue (lakhs) | 570.77 | 570.77 | 570.77 | 656.82 | 666.94 | |||||
| Earning Per Share (Rs) | 2.74 | 4.50 | 9.96 | 22.04 | 19.97 | |||||
| Equity Dividend (%) | 100.00 | 150.00 | 100.00 | 100.00 | 100.00 | |||||
| Book Value (Rs) | 19.20 | 21.89 | 28.09 | 82.08 | 104.54 | |||||
| ||||||||||
| Source : Asian CERC | ||||||||||
| ||||||||||